Global Breast Biopsy Market by Product (Assay Kits, Biopsy Needles, Biopsy Tables), Type (Liquid Breast Biopsy, Needle Breast Biopsy, Open Surgical Breast Biopsy), Guidance, Application - Forecast 2024-2030

The Breast Biopsy Market size was estimated at USD 1.00 billion in 2023, USD 1.09 billion in 2024, and is expected to grow at a CAGR of 9.26% to reach USD 1.87 billion by 2030.

A breast biopsy is a medical procedure for removing a sample of breast tissue for testing. The pathologists analyze the tissue sample in the medical labs to provide an appropriate medical diagnosis. The prevalence of breast cancer among women worldwide and the inclination of patients toward early diagnosis and treatment of diseases raise the need for diagnostic solutions such as breast biopsy procedures. Governments across countries are implementing breast cancer awareness programs encouraging individuals to undergo screening tests and necessitating advanced breast biopsy procedures. However, the high cost of breast biopsy procedures and the possibility of infections associated with the biopsy needles may prevent patients from undergoing the breast biopsy procedure. In addition, the ongoing clinical trials and the advent of liquid biopsy are expected to improve the diagnosis and patient outcome for breast cancer treatment.

Regional Insights

The surge in the incidence of breast cancer cases among women and the increase in the availability of advanced diagnostic treatment, coupled with the ongoing research on breast biopsy procedures, have increased the adoption of breast biopsy procedures among breast cancer patients in the Americas. The growing need for appropriate diagnosis and treatment for breast cancer to reduce breast cancer-related casualties and mitigate breast cancer risk factors are the factors that necessitate patients to avail of breast biopsy diagnostic procedures in the APAC region. The EMEA region has a significant need for breast biopsy diagnostic procedures owing to the increasing breast cancer awareness in older women and the rising need for improved diagnostic solutions for breast cancer. Additionally, significant investments by public and private organizations to expand the research on breast cancer are expected to improve and advance breast biopsy procedures.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Breast Biopsy Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Breast Biopsy Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Breast Biopsy Market, highlighting leading vendors and their innovative profiles. These include Argon Medical, Becton, Dickinson, and Company, Bio-Rad Laboratories, Inc, Biocept, Inc., Cook Group Incorporated, CooperSurgical, Inc., F. Hoffmann-La Roche Ltd., Fluxion Biosciences Inc., FUJIFILM Corporation, GE HealthCare, Guardant Health, Halma plc, Hologic, Inc., Illumina, Inc., INRAD, Inc., Iskus Health Ltd., Johnson & Johnson Services, Inc., Leica Biosystems Nussloch GmbH, Medtronic PLC, Merit Medical Systems, Siemens Healthineers, Sysmex Corporation, Thermo Fisher Scientific Inc., TransMed7, LLC, and Trivitron Healthcare.

Market Segmentation & Coverage

This research report categorizes the Breast Biopsy Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Product
  • Assay Kits
  • Biopsy Needles
  • Biopsy Tables
  • Guidance Systems
  • Liquid Biopsy Instruments
  • Localization Wires
• Type
  • Liquid Breast Biopsy
    • Circulating Tumor Cells
    • Circulating Tumor DNA
  • Needle Breast Biopsy
    • Core Needle Biopsy
    • Fine Needle Aspiration Biopsy
    • Vacuum-Assisted Biopsy
  • Open Surgical Breast Biopsy
    • Excisional
    • Incisional
• Guidance
  • Image-Guided Biopsy
    • Mammography-Guided Stereotactic Biopsy
    • MRI Guided Biopsy
    • Ultrasound-Guided Biopsy
  • Liquid Biopsy
    • Microarray-Based Biopsy
    • NGS-Based Biopsy
    • PCR-Based Biopsy
• Application
  • Early Cancer Screening
  • Recurrence Monitoring
  • Therapy Selection
  • Treatment Monitoring

• Region
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

The report offers valuable insights on the following aspects

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

1. What is the market size and forecast of the Breast Biopsy Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Breast Biopsy Market?
3. What are the technology trends and regulatory frameworks in the Breast Biopsy Market?
4. What is the market share of the leading vendors in the Breast Biopsy Market?
5. Which modes and strategic moves are suitable for entering the Breast Biopsy Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.